Exchange: NYSEMkt·Updated 07:50 PM EDT
AEON logo

AEON AEON Biopharma Inc. - Ordinary Shares - Class A

$0.2408
$0.0139
(5.46%)
Today
Closed $0.2408
$0.0082
(3.40%)
After Hours
Mkt Cap$12.01M
Vol758,718.00

About AEON

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
41

Bearish Sentiment

How do you feel about AEON?

Advertisement|Remove ads.